Organon, Samsung Bioepis launch HUMIRA biosimilar HADLIMA in US

Organon & Co. and Samsung Bioepis revealed that HADLIMA (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab), is now accessible to patients in the United States. This ... Read More